Carterra

Private

Salt Lake City, UtahHealthcare & Life Scienceshttps://carterra-bio.com/

Last Round

Series G

Dec 14, 2020

Momentum Score

25 /100

Company Overview

Carterra is a biotechnology company that provides a high-throughput biosensor platform intended to accelerate the discovery of novel therapeutic candidates.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Drug Discovery, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts, Services & Consulting

AI Layer

Infrastructure

Keywords

High-Throughput Surface Plasmon ResonanceHT-SPRbiomolecular interaction analysishigh-throughput screeningdrug discovery platformantibody characterizationflow printing microfluidicslab instrumentationepitope analysiskinetics analysislife science toolsbiosensor chipsantibody screeningsmall molecule screeningAI for drug discoveryAI life science infrastructure

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Carterra Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Carterra Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
Series G	Dec 14, 2020
VC Round	Jan 14, 2020
VC Round	Jan 17, 2018
VC Round	Jul 1, 2014
VC Round	May 30, 2012

View all Funding Rounds

Key People

Founding team and executive leadership

Tim Germann

Chief Commercial Officer

Executive Team

Carterra Investors

Notable investors and investment history

Investor	Rounds
Ballast Point Ventures	Series G, VC Round
Telegraph Hill Partners	VC Round, Series G
Park City Angels	VC Round
Pasadena Angels	VC Round
Pfizer	VC Round
TCA Venture Group	VC Round

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Jan 31, 2026
Monthly visitors increased 120% MoM, reaching 8.2K.
May 4, 2025
Monthly visitors increased 31% MoM, from 3.6K to 4.7K.

View all signals

Carterra Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Carterra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Carterra's valuation, stock price, and market status.

Firmographic Details

HeadquartersSalt Lake City, Utah

Employee Range81

Year Founded2005

Last FundingDec 14, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.